Milanova Tsveta
Chief Commercial Officer
1 company
Insider Signal Score
46
AverageTrades Analyzed
8
12M Win Rate
40.0%
Avg 3M Return
-10.1%
Avg 12M Return
-24.8%
Milanova Tsveta is a Chief Commercial Officer at AGIOS PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 0 buys and 8 sells.
Estimated insider holdings value: $1.3M based on current market prices.
Holdings by Company
AGIOJan 5, 2026
Current Shares37.7K
Value$1.32M
Net Activity-19,197
Bought: 0Sold: 19.2K
Transaction History
Showing 8 filings
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 5, 2026 | AGIO Agios Pharmaceuticals, Inc. | Chief Commercial Officer | Sale+OE | 2,872 | $27.02 | $77,601.44 | -7.6% | +26.8% | - | |
| Dec 30, 2025 | AGIO Agios Pharmaceuticals, Inc. | Chief Commercial Officer | Sale+OE | 2,932 | $27.09 | $79,427.88 | -9.1% | +8.3% | - | |
| Jun 24, 2025 | AGIO Agios Pharmaceuticals, Inc. | Chief Commercial Officer | Sale+OE | 2,770 | $33.54 | $92,905.80 | -9.6% | +14.3% | - | |
| Mar 3, 2025 | AGIO Agios Pharmaceuticals, Inc. | Chief Commercial Officer | Sale+OE | 1,681 | $35.54 | $59,742.74 | -6.8% | -1.5% | -14.0% | |
| Jan 6, 2025 | AGIO Agios Pharmaceuticals, Inc. | Chief Commercial Officer | Sale+OE | 2,804 | $32.18 | $90,232.72 | -12.9% | -22.8% | -18.1% | |
| Jan 24, 2024 | AGIO Agios Pharmaceuticals, Inc. | Chief Commercial Officer | Sale+OE | 1,618 | $21.64 | $35,013.52 | -10.9% | +47.9% | +64.5% | |
| Jan 5, 2024 | AGIO Agios Pharmaceuticals, Inc. | Chief Commercial Officer | Sale+OE | 2,902 | $22.32 | $64,772.64 | -23.6% | +20.7% | +39.1% | |
| Jun 30, 2023 | AGIO Agios Pharmaceuticals, Inc. | Chief Commercial Officer | Sale+OE | 1,618 | $28.36 | $45,886.48 | -29.7% | -12.5% | +52.3% |